{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:44:36Z","timestamp":1793508276663,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jconrel.2023.12.003","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T18:02:01Z","timestamp":1701885721000},"page":"583-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["MicroRNA-195 liposomes for therapy of Alzheimer's disease"],"prefix":"10.1016","volume":"365","author":[{"given":"Dan","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junkai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.12.003_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1474-4422(03)00349-1","article-title":"Immunotherapy for Alzheimer\u2019s disease","volume":"2","author":"Dodel","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","article-title":"Therapeutic strategies for Alzheimer\u2019s disease in clinical trials","volume":"68","author":"Godyn","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0020","article-title":"Donepezil for dementia due to Alzheimer\u2019s disease","volume":"6","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0025","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0030","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJMp2111320","article-title":"Controversy and progress in Alzheimer\u2019s disease - FDA approval of Aducanumab","volume":"385","author":"Rabinovici","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0035","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41593-020-00737-w","article-title":"Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life","volume":"23","author":"Uhlmann","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, Aducanumab, and Gantenerumab - binding profiles to different forms of amyloid-Beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease","volume":"20","author":"Soderberg","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0050","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","article-title":"Lecanemab: first approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0055","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/461895a","article-title":"Neuroscience: Alzheimer's disease","volume":"461","author":"Mucke","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0060","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/med.21434","article-title":"Drugs in clinical trials for Alzheimer\u2019s disease: the major trends","volume":"37","author":"Bachurin","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jep.2017.12.015","article-title":"Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer\u2019s disease","volume":"215","author":"Sahoo","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0070","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/med.21563","article-title":"Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer\u2019s disease","volume":"39","author":"Schaduangrat","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0075","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinations for Alzheimer\u2019s disease: current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101425","article-title":"The neurobiology of non-coding RNAs and Alzheimer\u2019s disease pathogenesis: pathways, mechanisms and translational opportunities","volume":"71","author":"Lauretti","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0085","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1523\/JNEUROSCI.1997-12.2013","article-title":"MicroRNA-195 protects against dementia induced by chronic brain Hypoperfusion via its anti-Amyloidogenic effect in rats","volume":"33","author":"Ai","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0090","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.brainresbull.2012.05.018","article-title":"MicroRNA-195 downregulates Alzheimer\u2019s disease amyloid-beta production by targeting BACE1","volume":"88","author":"Zhu","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0095","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1038\/s41380-020-0824-3","article-title":"MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer\u2019s disease pathogenesis","volume":"26","author":"Cao","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0100","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/jnc.13212","article-title":"Activation of Cdk5\/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation","volume":"134","author":"Sun","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neurobiolaging.2016.05.010","article-title":"Knockdown of microRNA-195 contributes to protein phosphatase-2A inactivation in rats with chronic brain hypoperfusion","volume":"45","author":"Liu","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0110","article-title":"MicroRNA-195 prevents dendritic degeneration and neuron death in rats following chronic brain hypoperfusion","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12974-020-01919-w","article-title":"MicroRNA-195 prevents hippocampal microglial\/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1\/CX3CR1 signaling","volume":"17","author":"Mao","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s10020-020-00150-w","article-title":"microRNA-195 attenuates neuronal apoptosis in rats with ischemic stroke through inhibiting KLF5-mediated activation of the JNK signaling pathway","volume":"26","author":"Chang","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0125","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/clinchem\/48.10.1647","article-title":"Stability of endogenous and added RNA in blood specimens, serum, and plasma","volume":"48","author":"Tsui","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0130","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/jcp.24344","article-title":"MicroRNA transport: a new way in cell communication","volume":"228","author":"Xu","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0135","doi-asserted-by":"crossref","first-page":"12679","DOI":"10.1039\/D1CS00029B","article-title":"Soft materials as biological and artificial membranes","volume":"50","author":"Tang","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.addr.2004.12.001","article-title":"Tat peptide-mediated cellular delivery: back to basics","volume":"57","author":"Brooks","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejpb.2012.12.020","article-title":"Liposomes modified with P-aminophenyl-alpha-D-mannopyranoside: a carrier for targeting cerebral functional regions in mice","volume":"84","author":"Hao","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0155","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00004647-199702000-00010","article-title":"Distribution of Glut1 glucose transporters in different brain structures compared to glucose utilization and capillary density of adult rat brains","volume":"17","author":"Zeller","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mt.2010.233","article-title":"Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy","volume":"19","author":"Ulasov","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0165","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/1061186X.2020.1744156","article-title":"Influences of different sugar ligands on targeted delivery of liposomes","volume":"28","author":"Zhang","year":"2020","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.06.029","article-title":"Tumor-selective lipopolyplex encapsulated small active RNA hampers colorectal cancer growth in vitro and in orthotopic murine","volume":"141","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0076-6879(05)91019-7","article-title":"Lymphoid tissue targeting of anti-HIV drugs using liposomes","volume":"391","author":"Desormeaux","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12885-022-09170-7","article-title":"Radiosynthesis of a novel antisense imaging probe targeting LncRNA HOTAIR in malignant glioma","volume":"22","author":"Ren","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejpb.2020.09.005","article-title":"Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy","volume":"156","author":"Chen","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0190","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1021\/acsami.5b11866","article-title":"Sialic acid-targeted Nanovectors with Phenylboronic acid-grafted Polyethylenimine robustly enhance siRNA-based cancer therapy","volume":"8","author":"Ji","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0195","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-4939-0320-7_34","article-title":"In vitro models of the blood-brain barrier","volume":"1135","author":"Czupalla","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0200","article-title":"BBB pathophysiology-independent delivery of siRNA in traumatic brain injury","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0205","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.biopsych.2022.04.019","article-title":"Astrocytes mediate cholinergic regulation of adult hippocampal neurogenesis and memory through M(1) muscarinic receptor","volume":"92","author":"Li","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0210","article-title":"Cellular affinity of particle-stabilized emulsion to boost antigen internalization","volume":"187","author":"Cao","year":"2022","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0215","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/1061186X.2021.1882469","article-title":"Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism","volume":"29","author":"Ren","year":"2021","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0220","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1096\/fj.02-0088com","article-title":"Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery","volume":"16","author":"Panyam","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.omtn.2021.02.015","article-title":"AhR\/miR-23a-3p\/PKCalpha axis contributes to memory deficits in ovariectomized and normal aging female mice","volume":"24","author":"Zhang","year":"2021","journal-title":"Mol. Ther. Nucleic acids"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/npr2.12150","article-title":"Decreased nesting behavior, selective increases in locomotor activity in a novel environment, and paradoxically increased open arm exploration in Neurogranin knockout mice","volume":"41","author":"Nakajima","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.633805","article-title":"Lentivirus-carried microRNA-195 rescues memory deficits of Alzheimer\u2019s disease transgenic mouse by attenuating the generation of amyloid plaques","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0240","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/03009858221075588","article-title":"Perfusion with 10% neutral-buffered formalin is equivalent to 4% paraformaldehyde for histopathology and immunohistochemistry in a mouse model of experimental autoimmune encephalomyelitis","volume":"59","author":"Snyder","year":"2022","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijpharm.2013.06.048","article-title":"Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT","volume":"454","author":"Tang","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0250","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00401-003-0688-z","article-title":"Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme","volume":"105","author":"Wolburg","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0260","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bcp.2014.01.011","article-title":"Behavioral assays with mouse models of Alzheimer\u2019s disease: practical considerations and guidelines","volume":"88","author":"Puzzo","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2015.02.020","article-title":"Donepezil attenuates Abeta-associated mitochondrial dysfunction and reduces mitochondrial Abeta accumulation in vivo and in vitro","volume":"95","author":"Ye","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0270","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.jalz.2007.11.013","article-title":"Disease-modifying approaches to Alzheimer\u2019s disease: challenges and opportunities-lessons from donepezil therapy","volume":"4","author":"Sabbagh","year":"2008","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/469679","article-title":"Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer\u2019s disease and Parkinson\u2019s disease)","volume":"2011","author":"Spuch","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0280","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.drudis.2018.11.001","article-title":"Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases","volume":"24","author":"Wang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/IJN.S23771","article-title":"Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting","volume":"7","author":"Xie","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.12.003_bb0290","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"Vives","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0295","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1074\/jbc.M211891200","article-title":"Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells","volume":"278","author":"Rudolph","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0300","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4161\/rna.21998","article-title":"Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs","volume":"9","author":"Shu","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0305","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCRESAHA.118.313563","article-title":"Getting to the heart of Alzheimer disease","volume":"124","author":"Tublin","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2023.12.003_bb0310","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","article-title":"Cerebrovascular disease in ageing and Alzheimer\u2019s disease","volume":"131","author":"Love","year":"2016","journal-title":"Acta Neuropathol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923007873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923007873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:53:44Z","timestamp":1759164824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923007873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":62,"alternative-id":["S0168365923007873"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.003","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-195 liposomes for therapy of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}